Filing Flows › Insight Molecular Diagnostics (IMDX) › Q2 2026 › vs Q1 2026
Insight Molecular Diagnostics (IMDX) Q2 2026 vs Q1 2026 (quarter over quarter)
Insight Molecular Diagnostics's revenue rose $207K (+647%) from $32K in Q1 2026 to $239K in Q2 2026.
Insight Molecular Diagnostics, Q2 2026: revenue $239K (-54% year over year), net loss $11.3M, operating cash flow −$9.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $239K | $32K | $207K | +647% |
| Other income, net | $142K | $123K | $19K | +15% |
| Net loss | $11.3M | $4.3M | $7.0M | +162% |
| Costs & expenses | $11.6M | $4.4M | $7.2M | +162% |
| Operating costs | $11.6M | $4.4M | $7.2M | +162% |
| Cost of revenue | $82K | $17K | $65K | +382% |
| Operating cash sources | $11.3M | $4.3M | $7.0M | +162% |
| Depreciation & amortization | $665K | $631K | $34K | +5% |
| Share-based compensation | $661K | $615K | $46K | +7% |
| Working capital & other | $666K | −$4.6M | $5.3M | — |
| Cash used in operations | $9.3M | $7.6M | $1.6M | +21% |
| Net loss absorbed | $11.3M | $4.3M | $7.0M | +162% |
Questions
How much did Insight Molecular Diagnostics's revenue grow quarter over quarter in Q2 2026?
Insight Molecular Diagnostics's revenue rose $207K (+647%) from $32K in Q1 2026 to $239K in Q2 2026.